TOP TALENT FROM DIVERSE BACKGROUNDS

Filter View:

Masayuki Kobayashi

PRESIDENT & REPRESENTATIVE DIRECTOR

TAIHO PHARMACEUTICAL CO., LTD.

Masa has held the position of President since April 2012, having joined Taiho Pharmaceutical Co., Ltd. in 1993. In his over 25 years with the organization, he considers the formation of Taiho Oncology Inc., his greatest accomplishment, and is most proud of his role as head of Taiho Global. He brings a background in political and law studies, as well as his extensive business experience.

Beyond his position at Taiho, Masa works with a variety of other organizations. He currently serves as Vice Chairman of the Pharmaceutical Association of Tokushima Prefecture in Japan, Committee Member of the Japan Pharmaceutical Manufacturers Association, and Councilor at the Federation of Pharmaceutical Manufacturers in Japan, Pharmaceutical Manufacturers Association of Tokyo, and the Kobayashi Foundation for Cancer Research.

TIM WHITTEN

PRESIDENT & CEO

TAIHO ONCOLOGY, INC.

Tim assumed the role of President & CEO in May 2018, having joined Taiho Pharma U.S.A., Inc. in February 2013 as Chief Commercial Officer. He is uniquely suited to the role, with an MBA and a pharmacy degree. Before joining Taiho, he served as President & CEO of Insmed, Inc., working to help patients with rare and serious lung diseases. Prior to Insmed, he was the President & CEO of Transave, Inc., and held senior management positions at Pharmacyclics and Bristol-Myers Squibb.

As the company’s first commercial hire, Tim oversaw the creation of the US commercial and Canadian businesses, with successful launches of LONSURF® (trifluridine and tipiracil) in both markets. Under his leadership, Taiho’s North American oncology commercial...

The Taiho Pharma Canada Leadership team brings strong leadership to the North American marketplace, while staying true to Taiho’s legacy of developing the highest quality pharmaceuticals that improve the lives of people everywhere.

MICHAEL SCHICK

PRESIDENT

Taiho Pharma Canada, Inc.

Michael is the current Chief Business Officer of the company’s US affiliate Taiho Oncology, Inc. He served as Taiho’s Chief Commercial Officer from 2017 to 2024 and its Vice President of Sales and Marketing from 2013 to 2016. He has been working in oncology since 1996, and began his career in the pharmaceutical and biotech industry at Abbott Pharmaceuticals. He has since had roles of increasing responsibility at Bristol-Myers Squibb Oncology, Pharmacia Oncology, Pharmacyclics, Amgen, ImClone Systems, and Allos Therapeutics. Michael has a proven track record of leadership that has consistently delivered excellent business and people development results. He earned his Bachelor of Arts from Villanova University.

Robert Tam

General Manager

Taiho Pharma Canada, Inc.

As General Manager of Taiho Pharma Canada, Bob leads the company’s mission to provide innovative oncology treatments that improve patients’ lives. He is responsible for leading and guiding the Canadian operations while ensuring new, innovative, and affordable oncology therapies are accessible to all Canadians. With a career spanning over 25 years in the pharmaceutical industry, Bob brings extensive experience in health technology assessment, government relations, and strategic leadership to the organization.

DR. AASTHA DOLLEY

SENIOR DIRECTOR, MEDICAL AFFAIRS

TAIHO PHARMA CANADA, INC.

Dr. Aastha Dolley is the Senior Director of Medical Affairs at Taiho Pharma Canada. In this role, she provides strategic medical leadership to support Taiho’s product development initiatives and oversees the implementation of Medical Affairs strategies for both approved and pipeline oncology products. Dr. Dolley also leads and manages the medical field team, ensuring alignment with organizational goals. Additionally, she is responsible for guiding the strategic planning and execution of optimal Health Canada registration pathways and post-approval commitments for Taiho Pharma's assets.

PIETER KOOIMAN

SENIOR DIRECTOR, FINANCE

TAIHO PHARMA CANADA, INC.

Pieter Kooiman is the Senior Director of Finance, having joined Taiho Pharma Canada, Inc. in April 2017 as the second employee and was instrumental in taking the organization from start-up to operating commercial company. He is responsible for all aspects of Taiho Pharma Canada’s finance function, including financial reporting, budgeting and forecasting, cash management, taxation, finance business partnering, and development and implementation of effective internal controls.